Evaluating Glucose Levels and Risk of Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor; Exercise Sub-Study

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: ba89234097dc46d45b32d0ef22cf5ce03e855f23
First added on: Mar 18, 2025